Market statusData NSENot investment advice
VIKAS LIFECARE

VIKAS LIFECARE Latest Share Price (VIKASLIFE)

TechnicalsTV Chart
1.21
0.01−0.82%
Overall Score70/100
Day range1
₹1.21
1
52-week1
₹1.21
2
Above low+15.2%
Below high48.9%
Range position12%
Open1.22
Prev Close1.22
Bid1.19583
Ask1.23364

TODAY IN ONE LINE

VIKASLIFE slipped 0.8% on average volume, lagging Nifty's 0.3% move.

With a market cap of ₹224.78 Cr., it trades at a P/E of 12.60. Track live valuations, technical indicators, and peers comparison below. Check delivery conviction and recent filings to build your view.

Volume1.5M43%vs 20D avg
Price Band20
Lower Band0.98
Upper Band1.46
Tick Size0.01
Daily Volatility2.47%
Annualised Vol47.19%
Market Cap₹224.78 Cr.
Promoter14.81%
Face Value₹1
Fwd P/E
PEG
EV/EBITDA
P/S0.52
ROA
Beta0.99
Div Payout
THE STOCK SCORE
Overall Score70/100
Updated 07 Sept

How good is this company?

Overall performance across 5 key dimensions.

Each card tappable → shows formula + inputs
FLAGS & NEWS

VIKAS LIFECARE flags & news 

Key strengths, potential risks, and recent updates.

3 green flags🚩 3 red flags

Green Flags

  • Healthy Operating MarginsOPM is structurally strong at 16.4%
  • Virtually Debt-FreeVery low Debt-to-Equity of 0.13x
  • Zero Pledge RiskNo recent active promoter pledging found

Red Flags

  • Sales ContractionQuarterly sales dropped 1.6% YoY
  • Low Promoter HoldingPromoters hold only 14.8%
  • Promoter SellingPromoter holding decreased by 14.20% QoQ

Latest VIKAS LIFECARE News

THE CHANGELOG

What changed recently?

Recent events, corporate actions, and announcements.

17 SEPT 2026
corporate
General Updates - Intimation of approval for extension of time for holding Annual General Meeting (AGM) for the financ...
View PDF
🔒Prime: full history + alerts on this stock
Valuation

VIKAS LIFECARE valuation: P/E, P/B and sector benchmarks.

Twelve years of multiples investors have paid for VIKAS LIFECARE, framed against the sector median so the premium or discount is obvious at a glance.

VIKAS LIFECARE trades at a P/E of 12.60× and P/B of 0.42×.

Key MetricsMarket + reported · 18 Sept 2026Consolidated

Market-priced ratios use the latest available quote; accounting metrics use the latest reported filing. Compare values with matched peers and the company's own history.

Valuation

Valuation

Market Cap
₹224.78 Cr.
P/E Ratio
12.6
P/B Ratio
0.42
EPS
₹-0.13
Profitability

Profitability

ROE
13.66%
ROCE
11.34%
Net Margin
-27.25%
Op Margin
16.41%
Growth

Growth

EPS YoY
Revenue YoY
-17.7%
Qtr Sales
-1.65%
Qtr Profit
-155.9%
Financial Health

Financial Health

Debt / Equity
0.13
Book Value
₹2.97
Div Yield
Promoter Holding
14.81%
Technicals

VIKAS LIFECARE technical analysis: indicators, pivots and CPR.

Latest RSI, MACD and moving-average signals plus the latest pivot and Central Pivot Range levels for VIKAS LIFECARE — derived from the latest tape, not yesterday's close.

VIKAS LIFECARE last traded at ₹1.21 with an intraday range of ₹1.21–₹1.24 — latest indicator, pivot and CPR signals below.

Last updated: 20 September 2026, 4:08 pm IST

Pivot points

Standard pivot — most widely referenced.

Pivot levels · Classic

Last: ₹1.21
LevelPrice (₹)Distance% Δ
R41.29+0.08+6.61%
R31.26+0.05+4.13%
R21.25+0.04+3.31%
R11.23+0.02+1.65%
PIVOT1.220.010.83%
CURRENT1.21
S11.20-0.01-0.83%
S21.19-0.02-1.65%
S31.17-0.04-3.31%
S41.14-0.07-5.79%
CPR Levels
Support
Resistance
S4
S3
S2
S1
| CPR |
BC: 1.21P: 1.22TC: 1.23
R1
R2
R3
R4
indicator
LTP: 1.21
PDH: 1.24
PDL: 1.20
● Market Sentiment

VIKASLIFE is trading Below CPR, indicating Bearishness

● CPR Width

CPR is Wider, suggesting unlikely for trending moves

● Opening Range

Day's range: 1.221.24

● Price Position

Trading Inside opening range

Financials

VIKAS LIFECARE financials: P&L, balance sheet, cash flow, ratios.

Reported annual and quarterly results for VIKAS LIFECARE — consolidated or standalone — with margins, YoY growth and key ratios inline.

VIKAS LIFECARE reports its full P&L, balance sheet, cash flow and ratios on this page — current market capitalisation of ₹224.78 Cr. and reported EPS of ₹-0.13.

iTap any row for a plain-English meaningChange vs a year ago — green means the move is healthy for that line, red means it isn’tDerivedCalculated by us, not reported directly
Mobile view
Latest vs previous year
MetricMar 2025Mar 2026
Revenue from Operations480
499
4.0%
Sales Growth YoY %Derived7.69%
4.03%
Other Income26
136
422.8%
Total Income506
635
25.5%
465
484
4.0%
Gross ProfitDerived15
16
4.4%
Gross Margin %Derived3.13%
3.14%
37
64
74.8%
EBITDA (Operating Profit)Derived-22
-48
123.7%
OPM %Derived-4.50%
-9.68%
5
12
131.0%
Profit Before Tax (PBT)-13
75
682.5%
-2
-11
474.5%
Effective Tax %Derived15.18%
-14.98%
Total Profit for Period-11
18
268.2%
Less: Non-controlling Interests
-0
Net Profit (Owner's PAT)Derived-11
18
268.6%
Net Profit Margin %Derived-2.27%
3.69%
PAT Growth YoY %Derived-177.81%
268.65%
Earnings Per Share (EPS ₹)-0.06
0.10
266.7%
Diluted Shares Outstanding (Cr)186
186
0.0%
Share of Profit from Associates/JVs
-68
Other Comprehensive Income (Net of Tax)4
1
69.0%
Total Expenses (incl. D&A & Interest)519
560
8.0%
Material Cost % of RevenueDerived3.56%
3.47%
Employee Cost % of RevenueDerived0.92%
0.84%
Other Cost % of RevenueDerived6.71%
11.99%
Interest Coverage (x)Derived-6.20x
-8.33x
Sales CAGR · 3Y
+1.6%
all values in ₹ Cr unless marked % / x / ₹ · fiscal-period end shown · reported figures via Stockezee financials API · annual results may be audited; quarterly results may be unaudited or limited-review
Segment Analysis

VIKAS LIFECARE segment analysis : revenue and profit mix.

Disclosed business segments at VIKAS LIFECARE with their share of revenue and profit, switchable between consolidated and standalone reporting.

VIKAS LIFECARE discloses revenue and profit across multiple business segments — toggle between consolidated and standalone views to see the mix.

Segment-wise Financial Analysis

Thesis

The Bull, Bear, and Flip case for VIKAS LIFECARE.

Our AI distills the core fundamental drivers supporting VIKAS LIFECARE, the risks that threaten it, and the quantitative conditions that could weaken the thesis.

VIKAS LIFECARE's investment case rests on 0 positive markers and 1 flagged concerns drawn from the latest reported filings.

bull case

What you're getting.

No strengths or opportunities on record.

bear case

Key Risks.

  • SWOT generation temporarily unavailable due to model error. The security token included in the request is invalid.

flip conditions

Flip Conditions.

  • Valuation risk. a P/E above 16 would leave less room for earnings disappointment.

  • Reassess if quarterly profit growth turns negative for two consecutive quarters. The bull case relies on compounding earnings.

  • Watch interest coverage if debt-to-equity climbs above 1.00. Balance sheet risk re-prices growth multiples fast.

  • Return-quality risk. ROE below 9% would indicate weaker capital compounding.

Shareholding

VIKAS LIFECARE shareholding pattern: promoters, FII, DII and public.

Quarter-on-quarter ownership shifts in VIKAS LIFECARE — who is buying, who is exiting, and which institutions hold the largest positions.

Shareholding Pattern

AnnualJun 2026

Public85.54%
Promoters14.20%
FII0.26%

Ownership Distribution

Retail & Public
85.54%
Promoters
14.20%
Foreign Institutions
0.26%

Category Trends

Foreign Institutions Breakdown
Total Holding: 0.26%
Net Change: +0.00%
Detailed Institutions5 institutions
Total Holding0.00%
Net Change+0.00%
Institution Name
Trend (Last 6)
Holding %
QoQ Change
YoY ChangePeriod
Elara India Opportunities Fund Limited
0.00%
0.00%
0.00%
Jun 2026
RADIANT GLOBAL FUND-CLASS B PARTICIPATING SHARES
0.00%
0.00%
0.00%
Jun 2026
EMINENCE GLOBAL FUND PCC- EUBILIA CAPITAL PARTNERS FUND I
0.00%
0.00%
0.00%
Jun 2026
Nomura Singapore Limited
0.00%
0.00%
0.00%
Jun 2026
Ag Dynamic Funds Limited
0.00%
0.00%
0.00%
Jun 2026
Peers

VIKAS LIFECARE peer comparison — same-sector benchmarks.

Same-sector listed peers ranked on P/E, market cap, dividend yield and growth — VIKAS LIFECARE is highlighted for quick read-across.

09 · Chart Patterns

VIKAS LIFECARE chart patterns: breakouts, tops and bottoms.

Auto-detected classical chart patterns for VIKAS LIFECARE — Double Top/Bottom, Head & Shoulders, Triple Bottom and more — with break levels, targets and quality scores across Intraday, Daily and Weekly timeframes.

Delivery Conviction

VIKAS LIFECARE delivery volume — last 20 sessions of conviction.

Daily traded volume and delivery percentage for VIKAS LIFECARE over 20 sessions — the gap between intraday flipping and genuine accumulation.

Latest session delivery in VIKAS LIFECARE stood at 54.1% of traded volume, against a 20-day average of 59.3%.

Avg Delivery (20D)59.3%-5.1 ppt latest vs avg
Highest Delivery76.8%on 21 Aug
Avg Volume (20D)25.71 L20-day run-rate
Conviction Trend↓ Weakening-5.1 ppt latest read
Volume & Delivery · last 20 sessions
Exchange Filings & Investor Updates

VIKAS LIFECARE announcements: results, concalls, ratings, M&A.

Filings VIKAS LIFECARE sent to the exchanges, sequenced as they hit the tape — concall transcripts, results, credit ratings and presentations.

VIKAS LIFECARE files concall transcripts, results, credit ratings and corporate-action notices on the NSE and BSE exchange portals — latest 56 documents below.

  1. 17 Sept 2026General UpdatesView PDF

    General Updates

    Intimation of approval for extension of time for holding Annual General Meeting (AGM) for the financial year ended March 31, 2026

  2. 08 Sept 2026General UpdatesView PDF

    General Updates

    Vikas Lifecare Limited has informed the Exchange about General Updates

  3. 10 Aug 2026Reply to Clarification- Financial resultsView PDF

    Reply to Clarification- Financial results

    The Exchange had sought clarification from Vikas Lifecare Limited for the quarter ended 31-Mar-2026 with respect to Regulation 33 of the SEBI…

  4. 31 Jul 2026Clarification - Financial ResultsView PDF

    Clarification - Financial Results

    The Exchange has sought clarification from Vikas Lifecare Limited for the quarter ended 30-Sep-2025 with respect to Regulation 33 of the SEBI…

  5. 17 Jul 2026Clarification - Financial ResultsView PDF

    Clarification - Financial Results

    The Exchange has sought clarification from Vikas Lifecare Limited for the quarter ended 30-Jun-2025 with respect to Regulation 33 of the SEBI…

Corporate Actions

VIKAS LIFECARE dividend history, splits and bonus issues.

Every dividend, stock split and bonus issue VIKAS LIFECARE has declared, sequenced by announce and record date.

VIKAS LIFECARE corporate-action history below covers all declared dividends, stock splits and bonus issues recorded with NSE and BSE.

About the Company

About VIKAS LIFECARE: business, sector, key facts.

What VIKAS LIFECARE does, where it operates, the people running it, and the numbers that describe the entity behind the ticker.

VIKAS LIFECARE operates in the Trading & Distributors industry under the Services sector, listed as NSE: VIKASLIFE, BSE: 542655.

VIKASLIFE
Services

VIKAS LIFECARE

NSE · VIKASLIFE·BSE · 542655·www.vikaslifecarelimited.com

Vikas Lifecare Limited is a multifaceted Indian company operating across diverse sectors, primarily focusing on trading and, to a lesser extent, manufacturing and R&D. Its business activities span several countries, including India, Mauritius, and Bangladesh. The company's structure is organized into four key divisions: Real Estate, Trading & Manufacturing (Agro), Trading & Manufacturing (Polymers), and Trading (Infrastructure). This diversified approach allows Vikas Lifecare to engage in a range of markets and capitalize on varying economic conditions.

A significant portion of Vikas Lifecare's business involves the trading of polymers and chemicals. This includes base polymers, additives, and chemicals essential for plastic processing. The company trades a wide range of polymer compounds such as EVA, PVC, PP, and PE, along with specialized compounds like V blend SOE compound, polypropylene compounds, and thermoplastic rubber compounds. This focus on the polymer sector positions Vikas Lifecare within a crucial area of the manufacturing industry, supplying raw materials to various downstream processes.

Beyond polymers, Vikas Lifecare engages extensively in the trading of other materials, including iron and steel, and various plastic products. In the infrastructure sector, the company supplies drinking water pipes, fittings, and bars. Furthermore, its involvement extends to the development of smart products, such as smart gas meters and power distribution solutions, highlighting a move towards technologically advanced offerings. The company also provides food-grade piping systems for drinking water applications, emphasizing its commitment to supplying materials for essential services.

Vikas Lifecare's agricultural sector operations involve the trading of agro products like rice and pulses, along with the processing and trading of cashew nuts and other premium consumer products. The company also undertakes research and development in horticulture, cultivation, preservation, and storage of agro products, illustrating an integrated approach to the agricultural value chain. This diversification into agriculture allows the company to tap into a different market segment and potentially achieve greater stability through less correlation between the performance of its various divisions.

In summary, Vikas Lifecare Limited is a dynamic trading company with a footprint across various sectors, leveraging its expertise in polymers and chemicals, infrastructure materials, and agro products. The company's diverse portfolio, combined with its international presence, contributes to its overall business strategy of minimizing risk and maximizing opportunities across different markets. The company’s commitment to research and development, particularly within the agro sector, suggests a strategy of long-term growth and expansion.

company facts
Employees
SectorServices
HeadquartersDelhi, India
Market Cap₹224.78 Cr.
Listed OnNSE
leadership16 on record
Dr. Samanta Yadav
Non-Executive Independent Director
Dr. Sundeep Kumar Dhawan M.Sc., Ph.D.
MD & Director
Mr. Amit Jindal
Chief Executive Officer
Mr. Anil Kumar
Non-Executive Independent Director
Mr. Anil Kumar Rawal
Executive Director
Mr. Chandan Kumar
Chief Financial Officer, Director - Finance
Mr. Chandan Kumar
CFO & Executive Director
Mr. Kamal Ghildiyal
Chief Operating Officer
Mr. Kamal Ghildiyal
Director of Commercial & Executive Director
Mr. Parag Dadeech
Whole-Time Director
Mr. Sanjay Jaiswal
Compliance Officer, Company Secretary
Mr. Sanjay Kumar Jaiswal
Company Secretary & Compliance Officer
§ ∞ · Plainly Answered

Questions investors ask about VIKAS LIFECARE (VIKASLIFE).

Quick answers grounded in this page's data — price action, fundamentals, ratios and ownership.

01What is the current share price of VIKAS LIFECARE (VIKASLIFE)?

The current share price of VIKAS LIFECARE (VIKASLIFE) is ₹1.21. Today, the stock has declined by ₹0.01 (0.82%), trading in a range of ₹1.21 to ₹1.24. The stock opened at ₹1.22 with a trading volume of 14,57,205 shares.

02Is VIKAS LIFECARE stock a good investment for long-term?

VIKAS LIFECARE can be considered for long-term investment based on several factors. The company has a market capitalization of ₹224.78 Cr., P/E ratio of 12.6, ROE of 13.66%, and ROCE of 11.34%. The dividend yield stands at 0%. However, investment decisions should be based on your financial goals, risk appetite, and thorough research. It's recommended to consult with a SEBI-registered financial advisor before making investment decisions.

03What is the 52-week high and low price of VIKAS LIFECARE stock?

The 52-week high price of VIKAS LIFECARE (VIKASLIFE) is ₹2.37, while the 52-week low is ₹1.05. Currently trading at ₹1.21, the stock is 15.24% above its 52-week low and 48.95% below its 52-week high. These levels help investors understand the stock's price volatility and trading range over the past year.

04Should I buy VIKAS LIFECARE stock at the current price?

Whether to buy VIKAS LIFECARE stock at ₹1.21 depends on multiple factors. The stock is currently trading with a P/E ratio of 12.6 and P/B ratio of 0.42. Today's performance shows a loss of 0.82%. Consider analyzing the company's fundamentals, technical indicators, industry trends, and your investment horizon. Compare these metrics with industry peers and consult a financial advisor for personalized advice.

05What is the dividend yield of VIKAS LIFECARE and when is the next dividend?

VIKAS LIFECARE offers a dividend yield of 0%, which means for every ₹100 invested at the current price of ₹1.21, you can expect to receive approximately ₹0.00 annually as dividends. The face value of the stock is ₹1.00. For information about the next dividend announcement and ex-dividend date, please check the company's official announcements or visit the BSE/NSE websites.

06What are the key financial ratios and metrics of VIKAS LIFECARE?

VIKAS LIFECARE's key financial metrics include: P/E Ratio: 12.6, P/B Ratio: 0.42, ROE: 13.66%, ROCE: 11.34%, Dividend Yield: 0%, EPS: ₹-0.13, Book Value: ₹2.97, and Debt-to-Equity: 0.13. The company's market cap stands at ₹224.78 Cr.. These metrics help evaluate the company's valuation, profitability, and financial health.

07How is VIKAS LIFECARE stock performing today in the market?

VIKAS LIFECARE stock opened at ₹1.22 and is currently trading at ₹1.21, showing a decline of ₹0.01 (0.82%). The intraday high is ₹1.24 and low is ₹1.21. The trading volume stands at 14,57,205 shares, indicating strong market participation today.

08What is the P/E ratio of VIKAS LIFECARE and what does it indicate?

VIKAS LIFECARE has a Price-to-Earnings (P/E) ratio of 12.6, which means investors are willing to pay 12.60 for every ₹1 of earnings. With an EPS of ₹-0.13, this P/E ratio suggests the stock may be undervalued or facing growth challenges. Compare this with industry peers and historical P/E ratios for better context.

Disclaimer

The data, ratios and commentary about VIKAS LIFECARE (VIKASLIFE) on this page are published for educational and informational purposes only and are not investment, legal or tax advice. StockeZee is not a SEBI-registered investment adviser, research analyst or portfolio manager, and no content here should be construed as a recommendation to buy, hold or sell any security. Live and historical market data may be delayed, revised by the exchanges, or contain errors; figures sourced from third-party feeds and corporate disclosures may not always be current. Past performance is not indicative of future results, and equity investments carry the risk of capital loss. Before acting on anything you read here, please consult a SEBI-registered financial advisor and read all scheme-related documents carefully.